NCT06152861Phase 2Unknown

Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2024-08Estimated

Enrollment · participants250Estimated

Source updated2023-12-06Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Study details

Conditions studied

Open Angle Glaucoma; Ocular Hypertension

Treatments or interventions studied

Travoprost Ophthalmic Topical Cream low-doseDrug
Travoprost Ophthalmic Topical Cream mid-doseDrug
Travoprost Ophthalmic Topical Cream high-doseDrug
Timolol maleate ophthalmic solution, 0.5%Drug
Travoprost Ophthalmic Solution, 0.004%Drug

Primary outcomes · main study measures

measure: change from baseline in mean diurnal IOP in the study eye; description: Day 29 mean diurnal IOP minus Baseline mean diurnal IOP in the study eye; timeFrame: Day 29

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history